VAERS Explorer
Back to explore

Report #2881889

Received Jan 14, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
57 yrs
State
NY
Recovered
Unknown
Vaccinated
Oct 5, 2021
Onset
Oct 5, 2021
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH330125BA—

Symptoms (4)

Biopsy lymph glandBody temperatureInfluenza like illnessUltrasound abdomen

Symptom narrative

flu like symptoms; This is a spontaneous report received from a Consumer or other non HCP. A 57-year-old female patient (not pregnant) received BNT162b2 (COMIRNATY), on 05Oct2021 as dose 3, single (Lot number: 30125BA) at the age of 57 years for covid-19 immunisation. The patient's relevant medical history included: "Asthma", start date: Oct1985 (unspecified if ongoing); "recently recurrence of Ovarian Cancer" (ongoing); "Allergies: Sulfate drugs", start date: 2000 (unspecified if ongoing), notes: Red rash, surgery; "Allergies: adhesive", start date: 2021 (unspecified if ongoing), notes: Red rash/burn; "Stage 3 ovarian cancer w/ massive ascites", start date: Feb2021, stop date: Sep2021; "Recurrence in medistinial to subclaviular lymph nodes", start date: 06Nov2025 (unspecified if ongoing). Concomitant medication(s) included: CRESTOR. Past drug history included: Flu shot, start date: 2000, for Flu immunisation, reaction(s): "Anaphylaxis"; Albuterol inhaler for Asthma, notes: 2 puffs 4-6 hours, Frequency- as needed; Tylenol for Headche, notes: 500 MG As needed; Ibuprofen for Fever, notes: 200 mg as needed. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: EN6207/ left arm), administration date: 11Mar2021, for COVID-19 IMMUNISATION; BNT162b2 (DOSE 2, SINGLE, Lot number: ER8734/ left arm), administration date: 01Apr2021, for COVID-19 IMMUNISATION; BNT162b2 (DOSE NUMBER UNKNOWN, SINGLE), administration date: 17Nov2023, for COVID-19 IMMUNISATION; BNT162b2 (DOSE NUMBER UNKNOWN, SINGLE), administration date: 14Nov2024, for COVID-19 IMMUNISATION. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 05Oct2021, outcome "unknown", described as "flu like symptoms". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: patient reported "flu like symptoms" following 05Oct2021 vaccination starting same day. It was unknown if it was vaccine or virus.

Current illness

Ovarian cancer recurrent

Medical history

Medical History/Concurrent Conditions: Adhesive tape allergy (Red rash/burn); Asthma; Metastases to lymph nodes; Ovarian cancer stage III; Sulfonamide allergy (Red rash, surgery)

Other medications

CRESTOR

Lab data

Test Date: 202511; Test Name: lymph node biopsy; Result Unstructured Data: Test Result:unknown; Comments: Shot received 4 days post lymph node biopsy; Test Date: 20251126; Test Name: body Temperature; Result Unstructured Data: Test Result:appox 99.5-101; Test Name: abdominal ultrasound; Result Unstructured Data: Test Result:other issues cleared